1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: XRP6976J_4001, NCT00280098
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.035, SUGEN-990711, NCT00004071
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor:
Protocol IDs: SAFR-CT-MM-2
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: DFCI-77001, NCI-T83-1310D, T83-1310
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-81001, NCI-D82-018-0400, D82-018-0400
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI
Protocol IDs: EST-PE-179
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
|
|
14.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 20
Sponsor:
Protocol IDs: ARG-GATLA-3LMA83
|
|
15.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8862
|
|
16.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 20
Sponsor:
Protocol IDs: ARG-GATLA-1LLAREC90, NCI-F92-0006, NCT00002499
|
|
17.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 70 and over
Sponsor: Other
Protocol IDs: EORTC-20991, NCT00060385
|
|
18.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 to 69
Sponsor: Other
Protocol IDs: JCOG0203, C000000033, NCT00147121
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: CLB-7784, CALGB-7784
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor: NCI
Protocol IDs: EST-4477
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 17
Sponsor:
Protocol IDs: GER-GPOH-AML-BFM-93, EU-93008
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 65
Sponsor:
Protocol IDs: MRC-ECUP, EU-93009
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI
Protocol IDs: SWOG-9321, CLB-9312, E-S9321, INT-0141, NCT00002548
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-5A93, NCT00002556, E5A93
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 50 and over
Sponsor:
Protocol IDs: EORTC-20932
|
